0001209191-19-003550.txt : 20190114 0001209191-19-003550.hdr.sgml : 20190114 20190114163415 ACCESSION NUMBER: 0001209191-19-003550 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190110 FILED AS OF DATE: 20190114 DATE AS OF CHANGE: 20190114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ambrogi Michael J. CENTRAL INDEX KEY: 0001654363 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 19525368 MAIL ADDRESS: STREET 1: 195 COMMERCE WAY CITY: PORTSMOUTH STATE: NH ZIP: 03801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-10 0 0001645113 NovoCure Ltd NVCR 0001654363 Ambrogi Michael J. C/O NOVOCURE INC. 20 VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355 0 1 0 0 Chief Operating Officer Ordinary Shares 2019-01-10 4 M 0 54930 14.37 A 201488 D Ordinary Shares 2019-01-10 4 S 0 20880 40.469 D 180608 D Ordinary Shares 2019-01-10 4 S 0 34050 41.14 D 146558 D Options to Buy Ordinary Shares 14.37 2019-01-10 4 M 0 54930 0.00 D 2025-02-23 Ordinary Shares 54930 37391 D These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi. On January 10, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 20,880 shares in multiple trades at prices ranging from $40.00 to $40.99. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. On January 10, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 34,050 shares in multiple trades at prices ranging from $41.00 to $41.45. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Fully vested as of the date hereof. /s/ Kimberly Burke, Attorney in fact for Michael J. Ambrogi 2019-01-14